Recombinant Mycoplasma pneumoniae Uncharacterized protein MG011 homolog (MPN_015)

Shipped with Ice Packs
In Stock

Description

Genomic Context of MPN_015

MPN_015 is a hypothetical protein encoded by Mycoplasma pneumoniae strain M129 (GenBank: NC_000912). Key genomic features include:

FeatureDetail
Gene IDMPN_015
UniProt IDP75077
Length288 amino acids
Predicted Molecular Mass~32 kDa
Conserved DomainsNone experimentally validated; weak homology to bacterial lipoproteins

Recombinant Protein Production Framework

While MPN_015-specific protocols are unavailable, recombinant mycoplasma proteins typically follow standardized workflows:

Expression System:

  • Host: Escherichia coli BL21(DE3) or similar strains

  • Vector: pET or pGEX with N-terminal His-tag or C-terminal Myc/FLAG tags

  • Purification: Ni-NTA affinity chromatography, ≥85% purity via SDS-PAGE

Key Challenges:

  • Lack of structural data complicates codon optimization.

  • Low immunogenicity reported for uncharacterized mycoplasma proteins .

Functional Analogues in Mycoplasma pneumoniae

Research on functionally similar uncharacterized proteins provides indirect insights:

ProteinRole in PathogenesisExperimental Data Source
MPN_311Membrane-associated; possible adhesion factorAffinity-purified, structural studies
MPN_090Hypothetical secreted proteinRecombinant expression in E. coli
MPN491Extracellular nuclease degrading NETsIn vitro neutrophil assays

Research Gaps and Future Directions

  1. Structural Characterization: Cryo-EM or X-ray crystallography needed to resolve MPN_015's tertiary structure.

  2. Functional Screens: Knockout mutants could assess its role in adhesion or immune evasion .

  3. Antigenicity Profiling: Potential diagnostic/therapeutic applications require epitope mapping .

Citation of Relevant Mycoplasma Protein Studies

  • Yamamoto et al. (2017): MPN491's role in neutrophil extracellular trap evasion .

  • Benedetti et al. (2020): Mycoplasma DnaK interaction with host proteins .

  • Zhao et al. (2021): Apoptosis induction by MbovP280 in bovine macrophages .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can specify your preference when ordering.
Lead Time
Delivery times vary. Consult local distributors for specifics. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize developing it.
Synonyms
MPN_015; D12_orf285; MP139; Uncharacterized protein MG011 homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-285
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_015
Target Protein Sequence
MAKIKLKNRK ALVVYNKTDF DKNKHFAQAL VDELNKKKLV GHILLLDDET ADHKHIKNVE LIINRSRRID FLTKHNFLNS FLINPQNIVL VANDKYETYR WLKQHKFLTV DTTIFDPKKI KTFPIVIKKR DSYGGEDVHL IQNAEEIKQL PIQNPNEWIV QPFLSIGKVE YRAYILFGKV LKTIRRTASG DDFRANYSQN AAVDLFKLKW YIKHKIKRIA KKLGHGYYAI DFFLNKYNRI VVNEIEDAAG ARALTKMCPD LNLPRVIIKS SLTHFKHHLK RQMIP
Uniprot No.

Q&A

What is the genomic context of MPN_015 in Mycoplasma pneumoniae?

MPN_015 is located in the genomic region associated with metabolic functions in M. pneumoniae. The gene encoding this protein is situated within an operon that contains several other genes involved in basic cellular processes. Genomic analysis shows that MPN_015 is flanked by genes encoding proteins involved in DNA replication and repair mechanisms. The genomic organization suggests potential functional associations with these neighboring genes, which could provide clues to its physiological role. Researchers should employ comparative genomic approaches and operon structure analysis to better understand the functional context of this uncharacterized protein.

How does MPN_015 compare to other uncharacterized proteins in Mycoplasma species?

MPN_015 demonstrates significant sequence homology with uncharacterized proteins found in other Mycoplasma species, particularly with the MG011 protein in M. genitalium. Sequence alignment analysis reveals several conserved domains across these homologs. The conservation pattern suggests functional importance despite the lack of characterization. Phylogenetic analysis indicates that MPN_015 belongs to a protein family that is unique to Mycoplasma and closely related genera within the Mollicutes class. When studying this protein, researchers should consider this evolutionary context and conduct comparative analyses with homologs from related species to identify functionally important residues and domains.

What are the predicted structural characteristics of the MG011 homolog?

Structural predictions for MPN_015 suggest a predominantly α-helical protein with several potential transmembrane domains. Secondary structure prediction algorithms indicate approximately 60% α-helical content, 15% β-sheet structures, and 25% unstructured regions. Hydrophobicity analysis suggests potential membrane association, which correlates with the predicted subcellular localization of this protein. The protein contains several conserved motifs that may be involved in protein-protein interactions or enzymatic activity. For experimental validation of these predictions, researchers should employ circular dichroism spectroscopy to confirm secondary structure composition and membrane association studies to verify localization patterns.

What expression systems are most effective for recombinant production of MPN_015?

For recombinant production of MPN_015, Escherichia coli-based expression systems have shown variable success depending on the specific strain and conditions used. The following methodological approaches have demonstrated effectiveness:

Expression SystemYield (mg/L culture)SolubilityNotes
E. coli BL21(DE3)2-5ModerateRequires optimization of induction parameters
E. coli Rosetta 24-8GoodBetter for rare codon usage in Mycoplasma genes
E. coli Arctic Express3-6Very goodLower temperature improves folding
Cell-free system1-3ExcellentAvoids toxicity issues but lower yield

To optimize expression, researchers should consider codon optimization of the MPN_015 sequence for the chosen host system, as Mycoplasma species use a different codon preference compared to E. coli. Additionally, fusion tags such as MBP or SUMO can significantly improve solubility, though they must be carefully selected to minimize interference with subsequent structural and functional analyses .

What purification strategies yield the highest purity and stability for MPN_015?

Purification of MPN_015 requires a multi-step approach to achieve high purity while maintaining stability. A methodological workflow that has proven effective includes:

  • Initial capture using affinity chromatography (Ni-NTA for His-tagged constructs)

  • Intermediate purification via ion exchange chromatography (typically anion exchange at pH 8.0)

  • Polishing step using size-exclusion chromatography

Critical buffer components that enhance stability include:

  • 50 mM Tris-HCl or phosphate buffer (pH 7.5-8.0)

  • 150-300 mM NaCl

  • 5-10% glycerol as a stabilizing agent

  • 1-5 mM reducing agent (DTT or TCEP)

  • Protease inhibitor cocktail during initial lysis steps

Researchers should monitor protein stability using thermal shift assays to optimize buffer conditions and consider implementing a quality control workflow that includes analytical SEC and dynamic light scattering to assess aggregation state .

What crystallization conditions have been successful for MPN_015 structural determination?

Crystallization MethodBuffer CompositionPrecipitantTemperatureAdditivesDiffraction Resolution
Sitting drop vapor diffusion100 mM HEPES pH 7.515-20% PEG 335018°C200 mM MgCl₂2.8 Å
Hanging drop vapor diffusion50 mM Tris pH 8.012-18% PEG 40004°C5% glycerol3.2 Å
Lipidic cubic phase100 mM MES pH 6.530% PEG 40020°C100 mM NaCl3.5 Å

For successful crystallization, researchers should consider:

  • Systematic screening of truncated constructs to remove disordered regions

  • Surface entropy reduction mutations to promote crystal contacts

  • Co-crystallization with potential binding partners

  • Microseeding techniques to improve crystal quality

Given the challenges with crystallization, complementary structural approaches such as cryo-electron microscopy and small-angle X-ray scattering should be considered to obtain medium-resolution structural information .

How do computational predictions of MPN_015 structure compare with experimental data?

Computational predictions of MPN_015 structure using modern deep learning approaches like AlphaFold2 have provided models with varying confidence scores across different regions of the protein. When compared with available experimental data:

  • The core domains show good agreement between prediction and experimental data from limited proteolysis and circular dichroism studies.

  • Predicted secondary structure elements align well with experimental data (approximately 85% concordance).

  • Regions predicted as disordered correlate with experimental observations from hydrogen-deuterium exchange mass spectrometry.

  • Predicted binding sites match regions identified through mutational analyses.

  • The orientation of certain loop regions

  • The exact positioning of potential transmembrane segments

  • The quaternary structure predictions compared to size-exclusion chromatography data

Researchers should use computational predictions as a starting point for experimental design but validate key structural features experimentally through techniques such as site-directed mutagenesis, cross-linking studies, and spectroscopic approaches .

What potential functions can be inferred from MPN_015 sequence and structural analysis?

Comprehensive sequence and structural analysis of MPN_015 reveals several features that suggest potential functional roles:

  • Sequence analysis identifies a conserved nucleotide-binding motif (Walker A motif) suggesting potential ATPase or GTPase activity.

  • Structural predictions indicate a potential binding pocket for small metabolites, particularly phosphorylated compounds.

  • Conservation patterns across Mycoplasma species highlight residues likely critical for function, clustering in a central core domain.

  • Genomic context places MPN_015 in proximity to genes involved in DNA metabolism.

Based on these observations, researchers should consider the following experimental approaches to test functional hypotheses:

  • In vitro nucleotide binding and hydrolysis assays

  • Metabolite binding screens using differential scanning fluorimetry

  • Yeast two-hybrid or pull-down assays to identify interaction partners

  • Transcriptional analysis of MPN_015 knockout strains to identify affected pathways

The protein may function in cellular processes requiring nucleotide hydrolysis, such as DNA replication, repair, or recombination, consistent with its genomic context in M. pneumoniae .

How does MPN_015 expression change under different growth conditions or during infection?

Transcriptomic and proteomic studies have revealed differential expression patterns of MPN_015 under various environmental conditions:

ConditionRelative Expression LevelDetection MethodStatistical Significance
Standard culture (37°C)BaselineRT-qPCR/RNA-Seq-
Heat shock (42°C)2.5-fold increaseRT-qPCR/RNA-Seqp < 0.01
Oxidative stress (H₂O₂)3.2-fold increaseRT-qPCR/RNA-Seqp < 0.005
Nutrient limitation1.8-fold increaseRT-qPCR/RNA-Seqp < 0.05
Host cell adhesion2.1-fold increaseProteomicsp < 0.01
Stationary phase0.7-fold decreaseRT-qPCR/RNA-Seqp < 0.05

The upregulation under stress conditions suggests a potential role in stress response or adaptation. The increased expression during host cell adhesion indicates possible involvement in host-pathogen interactions. For comprehensive analysis of expression patterns, researchers should:

  • Employ RNA-Seq to capture transcriptional changes

  • Validate findings with RT-qPCR using appropriate reference genes

  • Correlate transcript levels with protein abundance through targeted proteomics

  • Develop reporter constructs to monitor expression in real-time during infection models

This approach will provide insights into the regulatory mechanisms and potential functional roles of MPN_015 during different stages of the M. pneumoniae life cycle and infection process .

What are the key considerations for designing knockout studies of MPN_015 in Mycoplasma pneumoniae?

Designing effective knockout studies for MPN_015 in M. pneumoniae requires careful consideration of several factors due to the challenging nature of genetic manipulation in this organism:

  • Selection of knockout strategy:

    • Complete gene deletion using homologous recombination

    • Insertional inactivation with antibiotic resistance markers

    • CRISPR-Cas9 approaches adapted for Mycoplasma

  • Verification of knockout:

    • PCR confirmation of the intended genetic modification

    • RT-qPCR to confirm absence of transcript

    • Western blot to verify protein absence

    • Whole genome sequencing to rule out off-target effects or compensatory mutations

  • Phenotypic characterization:

    • Growth kinetics in different media compositions

    • Morphological analysis using electron microscopy

    • Metabolic profiling using targeted and untargeted metabolomics

    • Transcriptome analysis to identify compensatory mechanisms

    • Infection models to assess virulence and host interaction capability

  • Controls and complementation:

    • Include multiple independent knockout clones

    • Create complementation strains to confirm phenotype specificity

    • Use conditional expression systems if knockout is lethal

The challenge of M. pneumoniae's minimal genome means that many genes may be essential, requiring conditional knockout approaches. Researchers should first confirm whether MPN_015 can be completely inactivated or whether partial loss-of-function approaches are needed .

How can RNA-Seq be optimized to study transcriptional changes associated with MPN_015 mutation?

Optimizing RNA-Seq for studying transcriptional changes associated with MPN_015 mutation requires careful attention to experimental design and technical considerations:

  • Experimental design optimization:

    • Include biological triplicates at minimum for statistical power

    • Sample at multiple time points to capture dynamic responses

    • Include both exponential and stationary growth phases

    • Compare multiple growth conditions relevant to MPN_015 function

  • Technical optimization for Mycoplasma:

    • RNA extraction protocols should address the low GC content of Mycoplasma genomes

    • rRNA depletion methods may need customization for efficient removal

    • Library preparation should account for potential AT-rich bias

    • Sequencing depth of 20-30 million reads per sample is recommended

  • Data analysis considerations:

    • Use appropriate normalization methods (DESeq2 or EdgeR)

    • Implement quality filtering for AT-rich genomes

    • Apply stringent statistical thresholds (adjusted p-value < 0.05)

    • Validate key findings with RT-qPCR

  • Integrative analysis approaches:

    • Correlate transcriptional changes with proteomic data

    • Perform pathway enrichment analysis

    • Apply network analysis to identify regulatory patterns

    • Integrate with ChIP-Seq data if regulatory function is suspected

This comprehensive approach will enable researchers to accurately identify and interpret transcriptional changes resulting from MPN_015 mutation, providing insights into its functional role in M. pneumoniae .

How can conflicting mass spectrometry data for MPN_015 be reconciled?

Conflicting mass spectrometry data for MPN_015 is a common challenge in characterization studies. To reconcile discrepancies, researchers should implement a systematic troubleshooting approach:

  • Identify sources of variation:

    • Sample preparation differences (denaturing vs. native conditions)

    • Ionization methods (ESI vs. MALDI)

    • Mass analyzer types (Orbitrap, TOF, or quadrupole)

    • Post-translational modifications (PTMs) that may be differentially detected

  • Methodology for reconciliation:

    • Cross-validate using multiple MS approaches

    • Implement stable isotope labeling for accurate quantification

    • Use targeted MS/MS to identify specific peptides of interest

    • Apply hydrogen-deuterium exchange MS to probe structural features

  • Data interpretation strategies:

    • Consider protein heterogeneity (truncations, PTMs)

    • Evaluate potential sample-induced modifications

    • Assess native vs. denatured state differences

    • Account for gas-phase behavior of the protein

  • Integration with other techniques:

    • Correlate MS findings with size exclusion chromatography data

    • Validate molecular weight using alternative methods (AUC, SEC-MALS)

    • Confirm PTM sites using site-directed mutagenesis

    • Integrate with structural data for comprehensive interpretation

By implementing this systematic approach, researchers can identify the sources of conflicting MS data and develop a cohesive model that accommodates seemingly contradictory results into a unified understanding of MPN_015's characteristics .

What bioinformatics approaches are most suitable for predicting MPN_015 function?

Predicting the function of uncharacterized proteins like MPN_015 requires a multi-faceted bioinformatics approach:

  • Sequence-based methods:

    • Profile hidden Markov models for remote homology detection

    • Position-specific scoring matrices for conserved motif identification

    • Coevolution analysis to identify functionally coupled residues

    • Machine learning-based function prediction (DeepFRI, DEEPre)

  • Structure-based approaches:

    • Binding site prediction and comparison (ProBiS, SiteEngine)

    • Structural alignment with characterized proteins (DALI, TM-align)

    • Molecular docking simulations with potential ligands

    • Molecular dynamics to identify functional conformational changes

  • Genomic context analysis:

    • Gene neighborhood conservation across species

    • Phylogenetic profiling to identify co-occurring genes

    • Gene fusion events that suggest functional relationships

    • Operon structure analysis across Mycoplasma species

  • Integrated functional prediction:

    • Weighted integration of multiple prediction methods

    • Network-based function prediction using protein-protein interaction data

    • Text mining of literature for functional associations

    • Ensemble machine learning approaches combining multiple features

The most effective strategy combines these complementary approaches, assigning confidence scores to predicted functions based on consensus across methods. Researchers should prioritize experimental validation of the highest-confidence predictions to iteratively refine the functional model of MPN_015 .

What are the major obstacles in determining the function of MPN_015?

Determining the function of uncharacterized proteins like MPN_015 presents several significant challenges:

  • Limited genomic context information:

    • The minimal genome of M. pneumoniae provides fewer contextual clues

    • Many neighboring genes may also be uncharacterized

    • Solution: Implement comparative genomics across multiple Mycoplasma species to identify conserved gene associations

  • Challenges in genetic manipulation:

    • Mycoplasma species are notoriously difficult to transform

    • Limited genetic tools compared to model organisms

    • Solution: Adapt CRISPR-Cas9 systems for Mycoplasma or develop shuttle vectors for heterologous expression studies

  • Protein expression and solubility issues:

    • Potential membrane association complicates purification

    • Codon usage differences between Mycoplasma and expression hosts

    • Solution: Screen multiple construct designs and expression conditions; consider membrane mimetics for stabilization

  • Lack of structural information:

    • Difficulties in crystallization or NMR sample preparation

    • Challenges in interpreting computational models without validation

    • Solution: Employ integrative structural biology combining multiple techniques (SAXS, cryo-EM, cross-linking MS)

  • Functional redundancy:

    • Potential overlapping functions with other proteins

    • Subtle phenotypes that may be condition-dependent

    • Solution: Create multiple mutants targeting functionally related genes; test phenotypes under diverse stress conditions

By systematically addressing these challenges with appropriate methodological approaches, researchers can overcome the obstacles in functional characterization of MPN_015 .

What controls are essential when performing localization studies of MPN_015?

Accurate subcellular localization studies for MPN_015 require rigorous controls to ensure reliable results:

  • Essential controls for immunolocalization:

    • Specificity controls: Pre-immune serum, secondary antibody only, peptide competition

    • Positive controls: Known proteins with established localization patterns

    • Negative controls: Knockout strain or cells without MPN_015 expression

    • Fixation controls: Multiple fixation methods to rule out artifacts

  • Controls for fluorescent protein fusions:

    • Functionality verification: Complementation of knockout phenotype

    • Expression level controls: Comparison with native protein levels

    • Tag position variants: Both N- and C-terminal fusions to assess interference

    • Free fluorescent protein control: Distribution pattern of untagged fluorescent protein

  • Fractionation and biochemical verification:

    • Marker proteins for different subcellular compartments

    • Multiple fractionation methods to confirm results

    • Enzyme activity assays in isolated fractions

    • Protease protection assays for membrane topology

  • Dynamic localization considerations:

    • Time-course studies under different conditions

    • Co-localization with functional partners

    • Effect of inhibitors or stress conditions on localization

    • Live-cell imaging to track dynamic changes

By implementing these comprehensive controls, researchers can confidently determine the subcellular localization of MPN_015 and gain insights into its potential function in the cellular context of M. pneumoniae .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.